박출률 시장 규모, 점유율, 동향 분석 보고서 : 용도별, 기술별, 디바이스별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

Ejection Fraction Market Summary

The global ejection fraction market size was estimated at USD 6.3 billion in 2025 and is projected to reach USD 12.4 billion by 2033, growing at a CAGR of 8.0% from 2026 to 2033. The market is driven by the rising prevalence of heart failure and other cardiovascular diseases, which increase the need for regular and precise ejection fraction assessment.

Advances in non-invasive imaging technologies, such as AI-enabled echocardiography and cardiac MRI, are improving measurement accuracy and workflow efficiency. Growing adoption of remote monitoring solutions and integration with hospital information systems are enabling continuous patient management and early detection of cardiac deterioration, further developing the use of EF monitoring devices.

Global Ejection Fraction Market Report Segmentation

This report forecasts revenue growth and provides, at the global, regional, and country levels, an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global ejection fraction market report based on device type, technology, application, and region:

• Device Type Outlook (Revenue, USD Million, 2021 - 2033)
• Echocardiography Systems
  • 2D echocardiography
  • 3D/4D echocardiography
  • Doppler imaging systems
• Cardiac MRI Systems
• Cardiac CT Systems
• Nuclear Imaging Systems (MUGA scanners)
• Implantable Cardiac Devices (ICD, CRT, VAD)
• Cardiac Monitoring Devices & Wearables
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Ultrasound Based
• Magnetic Resonance Based
• CT Based
• Nuclear Imaging Based
• AI Enabled EF Measurement
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Heart Failure Management
• Cardiomyopathy & Ischemic Heart Disease
• Valvular Heart Disease
• Oncology Cardiac Monitoring
• Surgical & Critical Care Assessment
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Care Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Device type outlook
  • 2.2.2. Technology outlook
  • 2.2.3. Application outlook
  • 2.2.4. End use outlook
• 2.3. Competitive Insights

Chapter 3. Global Ejection Fraction Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Global Ejection Fraction: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Landscape
• 3.5. Case Study Analysis

Chapter 4. Global Ejection Fraction Market Segment Analysis, By Device Type, 2021-2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Device Type Market Share Analysis, 2025 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Ejection Fraction Market, by Device Type, 2021 to 2033
• 4.5. Echocardiography Systems
  • 4.5.1. Echocardiography systems market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.2. 2D echocardiography
    • 4.5.2.1. 2D echocardiography market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.3. 3D/4D echocardiography
    • 4.5.3.1. 3D/4D echocardiography market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5.4. Doppler imaging systems
    • 4.5.4.1. Doppler imaging systems market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Cardiac MRI Systems
  • 4.6.1. Cardiac MRI systems market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.7. Cardiac CT Systems
  • 4.7.1. Cardiac CT systems market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.8. Nuclear Imaging Systems (MUGA scanners)
  • 4.8.1. Nuclear imaging systems (MUGA scanners) market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.9. Implantable Cardiac Devices (ICD, CRT, VAD)
  • 4.9.1. Implantable cardiac devices (ICD, CRT, VAD) market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.10. Cardiac Monitoring Devices & Wearables
  • 4.10.1. Cardiac monitoring devices & wearables market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Ejection Fraction Market Segment Analysis, By Technology, 2021-2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Technology Market Share Analysis, 2025 & 2033
• 5.3. Segment Dashboard
• 5.4. Global Ejection Fraction Market, by Technology, 2021 to 2033
• 5.5. Ultrasound Based
  • 5.5.1. Ultrasound based market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Magnetic Resonance Based
  • 5.6.1. Magnetic resonance based market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. CT Based
  • 5.7.1. CT based market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Nuclear Imaging Based
  • 5.8.1. Nuclear imaging based market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.9. AI Enabled EF Measurement
  • 5.9.1. AI enabled EF measurement market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Global Ejection Fraction Market Segment Analysis, By Application, 2021-2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. Application Market Share Analysis, 2025 & 2033
• 6.3. Segment Dashboard
• 6.4. Global Ejection Fraction Market, by Application, 2021 to 2033
• 6.5. Heart Failure Management
  • 6.5.1. Heart failure management market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. Cardiomyopathy & Ischemic Heart Disease
  • 6.6.1. Cardiomyopathy & ischemic heart disease market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Valvular Heart Disease
  • 6.7.1. Valvular heart disease market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.8. Oncology Cardiac Monitoring
  • 6.8.1. Oncology cardiac monitoring market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.9. Surgical & Critical Care Assessment
  • 6.9.1. Surgical & critical care assessment market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Global Ejection Fraction Market Segment Analysis, By End Use, 2021-2033 (USD Million)

• 7.1. Definition and Scope
• 7.2. End Use Market Share Analysis, 2025 & 2033
• 7.3. Segment Dashboard
• 7.4. Global Ejection Fraction Market, by End Use, 2021 to 2033
• 7.5. Hospitals
  • 7.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.6. Ambulatory Care Centers
  • 7.6.1. Ambulatory care centers market estimates and forecasts, 2021 to 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Ejection Fraction Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 8.1. Regional Market Share Analysis, 2025 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Regional Market Snapshot
• 8.4. Ejection Fraction Market Share by Region, 2025 & 2033
• 8.5. North America
  • 8.5.1. North America ejection fraction market, 2021 - 2033 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Regulatory Scenario
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. U.S. ejection fraction market, 2021 - 2033 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Regulatory Scenario
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Canada ejection fraction market, 2021 - 2033 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Regulatory Scenario
    • 8.5.4.3. Competitive Scenario
    • 8.5.4.4. Mexico ejection fraction market, 2021 - 2033 (USD Million)
• 8.6. Europe
  • 8.6.1. Europe ejection fraction market, 2021 - 2033 (USD Million)
  • 8.6.2. UK
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Regulatory Scenario
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. UK ejection fraction market, 2021 - 2033 (USD Million)
  • 8.6.3. Germany
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Regulatory Scenario
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Germany ejection fraction market, 2021 - 2033 (USD Million)
  • 8.6.4. France
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Regulatory Scenario
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. France ejection fraction market, 2021 - 2033 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Regulatory Scenario
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Italy ejection fraction market, 2021 - 2033 (USD Million)
  • 8.6.6. Spain
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Regulatory Scenario
    • 8.6.6.3. Competitive Scenario
    • 8.6.6.4. Spain ejection fraction market, 2021 - 2033 (USD Million)
  • 8.6.7. Norway
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Regulatory Scenario
    • 8.6.7.3. Competitive Scenario
    • 8.6.7.4. Norway ejection fraction market, 2021 - 2033 (USD Million)
  • 8.6.8. Sweden
    • 8.6.8.1. Key Country Dynamics
    • 8.6.8.2. Regulatory Scenario
    • 8.6.8.3. Competitive Scenario
    • 8.6.8.4. Sweden ejection fraction market, 2021 - 2033 (USD Million)
  • 8.6.9. Denmark
    • 8.6.9.1. Key Country Dynamics
    • 8.6.9.2. Regulatory Scenario
    • 8.6.9.3. Competitive Scenario
    • 8.6.9.4. Denmark ejection fraction market, 2021 - 2033 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Japan
    • 8.7.1.1. Key Country Dynamics
    • 8.7.1.2. Regulatory Scenario
    • 8.7.1.3. Competitive Scenario
    • 8.7.1.4. Japan ejection fraction market, 2021 - 2033 (USD Million)
  • 8.7.2. China
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Regulatory Scenario
    • 8.7.2.3. Competitive Scenario
    • 8.7.2.4. China ejection fraction market, 2021 - 2033 (USD Million)
  • 8.7.3. India
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Regulatory Scenario
    • 8.7.3.3. Competitive Scenario
    • 8.7.3.4. India ejection fraction market, 2021 - 2033 (USD Million)
  • 8.7.4. Australia
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Regulatory Scenario
    • 8.7.4.3. Competitive Scenario
    • 8.7.4.4. Australia ejection fraction market, 2021 - 2033 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Regulatory Scenario
    • 8.7.5.3. Competitive Scenario
    • 8.7.5.4. South Korea ejection fraction market, 2021 - 2033 (USD Million)
  • 8.7.6. Thailand
    • 8.7.6.1. Key Country Dynamics
    • 8.7.6.2. Regulatory Scenario
    • 8.7.6.3. Competitive Scenario
    • 8.7.6.4. Thailand ejection fraction market, 2021 - 2033 (USD Million)
• 8.8. Latin America
  • 8.8.1. Brazil
    • 8.8.1.1. Key Country Dynamics
    • 8.8.1.2. Regulatory Scenario
    • 8.8.1.3. Competitive Scenario
    • 8.8.1.4. Brazil ejection fraction market, 2021 - 2033 (USD Million)
  • 8.8.2. Argentina
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Regulatory Scenario
    • 8.8.2.3. Competitive Scenario
    • 8.8.2.4. Argentina ejection fraction market, 2021 - 2033 (USD Million)
• 8.9. MEA
  • 8.9.1. South Africa
    • 8.9.1.1. Key Country Dynamics
    • 8.9.1.2. Regulatory Scenario
    • 8.9.1.3. Competitive Scenario
    • 8.9.1.4. South Africa ejection fraction market, 2021 - 2033 (USD Million)
  • 8.9.2. Saudi Arabia
    • 8.9.2.1. Key Country Dynamics
    • 8.9.2.2. Regulatory Scenario
    • 8.9.2.3. Competitive Scenario
    • 8.9.2.4. Saudi Arabia ejection fraction market, 2021 - 2033 (USD Million)
  • 8.9.3. UAE
    • 8.9.3.1. Key Country Dynamics
    • 8.9.3.2. Regulatory Scenario
    • 8.9.3.3. Competitive Scenario
    • 8.9.3.4. UAE ejection fraction market, 2021 - 2033 (USD Million)
  • 8.9.4. Kuwait
    • 8.9.4.1. Key Country Dynamics
    • 8.9.4.2. Regulatory Scenario
    • 8.9.4.3. Competitive Scenario
    • 8.9.4.4. Kuwait ejection fraction market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis, By Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Profiles
  • 9.3.1. GE HealthCare
    • 9.3.1.1. Company overview
    • 9.3.1.2. Financial performance
    • 9.3.1.3. Product benchmarking
    • 9.3.1.4. Strategic initiatives
  • 9.3.2. Koninklijke Philips
    • 9.3.2.1. Company overview
    • 9.3.2.2. Financial performance
    • 9.3.2.3. Product benchmarking
    • 9.3.2.4. Strategic initiatives
  • 9.3.3. Siemens Healthineers
    • 9.3.3.1. Company overview
    • 9.3.3.2. Financial performance
    • 9.3.3.3. Product benchmarking
    • 9.3.3.4. Strategic initiatives
  • 9.3.4. Canon Medical Systems
    • 9.3.4.1. Company overview
    • 9.3.4.2. Financial performance
    • 9.3.4.3. Product benchmarking
    • 9.3.4.4. Strategic initiatives
  • 9.3.5. Fujifilm Healthcare
    • 9.3.5.1. Company overview
    • 9.3.5.2. Financial performance
    • 9.3.5.3. Product benchmarking
    • 9.3.5.4. Strategic initiatives
  • 9.3.6. Mindray Medical International Ltd.
    • 9.3.6.1. Company overview
    • 9.3.6.2. Financial performance
    • 9.3.6.3. Product benchmarking
    • 9.3.6.4. Strategic initiatives
  • 9.3.7. Samsung Medison Co., Ltd.
    • 9.3.7.1. Company overview
    • 9.3.7.2. Financial performance
    • 9.3.7.3. Product benchmarking
    • 9.3.7.4. Strategic initiatives
  • 9.3.8. Esaote SPA
    • 9.3.8.1. Company overview
    • 9.3.8.2. Financial performance
    • 9.3.8.3. Product benchmarking
    • 9.3.8.4. Strategic initiatives
  • 9.3.9. Butterfly Network, Inc.
    • 9.3.9.1. Company overview
    • 9.3.9.2. Financial performance
    • 9.3.9.3. Product benchmarking
    • 9.3.9.4. Strategic initiatives
  • 9.3.10. Terason Division
    • 9.3.10.1. Company overview
    • 9.3.10.2. Financial performance
    • 9.3.10.3. Product benchmarking
    • 9.3.10.4. Strategic initiatives
  • 9.3.11. Teratech Corporation
    • 9.3.11.1. Company overview
    • 9.3.11.2. Financial performance
    • 9.3.11.3. Product benchmarking
    • 9.3.11.4. Strategic initiatives
  • 9.3.12. iCardio.ai
    • 9.3.12.1. Company overview
    • 9.3.12.2. Financial performance
    • 9.3.12.3. Product benchmarking
    • 9.3.12.4. Strategic initiatives